theheartorg | Medscape ✓

@theheartorg · US, UK, Canada · joined 21 Sep 2008

theheartorg | Medscape Cardiology is your best source for cardiovascular disease news online.

43 521Followers

1 579Following

29 078Posts total

2.6KViews on collected posts

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. below its peers on both reach and engagement.

Median views584this account1 133median for 10K–100K

Reach, %1.34%this account3.62%median for 10K–100K

Engagement, %0.30%this account2.00%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	584	1 133	0.52×
Reach (views ÷ followers)	1.34%	3.62%	0.37×
Engagement rate	0.30%	2.00%	0.15×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

6243 Sep

6634 Sep

354

584

416

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.32%3 Sep

0.30%4 Sep

0.00%

0.34%

0.00%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 2.00%.

What the audience does

Likes71.4%5 in total

Reposts14.3%1 in total

Bookmarks14.3%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

SAVE THE DATE 🗓️ Join Dr. Anjali Tiku Owens as she shares actionable frameworks to optimize therapy and transition to CMIs. 🗓️ Sept 14th ⏰ 12:00pm ET 🔗 https://t.co/jgIMx6Q7Nc #Cardiology #oHCM #CME https://t.co/oRfxkl89bs 416 views · 0 likes · 0 reposts · 0 replies 04 Sep 2026 · Open on X →

🧠 Recurrent stroke carries a profound human burden—but prevention is evolving. Explore patient-relevant evidence for factor XIa inhibitors. 🧬, phase 3 patient profiles & their emerging risk-benefit picture ⚖️ Stay ahead of what’s next 👉 https://t.co/PjtnWlhIEA https://t.co/tl 584 views · 1 likes · 1 reposts · 0 replies 04 Sep 2026 · Open on X →

Lipid management remains a cornerstone of cardiovascular risk reduction. This World Heart Month, reassess treatment targets, intensify lipid-lowering therapy where indicated, and adopt comprehensive evidence-based strategies to reduce cardiovascular morbidity and mortality in htt 354 views · 0 likes · 0 reposts · 0 replies 04 Sep 2026 · Open on X →

🧬 Could factor XIa inhibition reshape secondary stroke prevention? Explore the science behind targeting factor XI/XIa, review the 🧪 latest trial data & identify patients who may benefit from this emerging approach. 🚀 Stay ahead of the evidence—register today! https://t.co/7ST 663 views · 2 likes · 0 reposts · 0 replies 04 Sep 2026 · Open on X →

⚡ Act earlier in outpatient HF care! Recognize decompensation, personalize SC diuretic therapy, integrate wearable data, and build collaborative pathways 🤝. #HFSA2026 https://t.co/Fz3WQF7OAJ https://t.co/ja8YHQkrWP 624 views · 2 likes · 0 reposts · 0 replies 03 Sep 2026 · Open on X →